English: Thank you for the comments and the series of questions. I certainly can't provide all the detail that I would be able to. I would take up the time of several other Ministers. We could have the whole afternoon simply talking about all of the various different areas that will affect the health and social care system if there is a 'no deal' Brexit. On radioisotopes, I've repeatedly made this point about the challenge not just of actually providing radioisotopes into the country physically, but challenges about regulation on whether manufacturers can legally import radioisotopes into the United Kingdom, especially if the United Kingdom does continue with its current proposal to withdraw from Euratom and there is a 'no deal' Brexit. There are ongoing conversations about that. The British Medical Association themselves, for example, have produced a briefing raising some challenges about that. The UK Government currently say that they have in place - or they're confident they will have in place - arrangements to make sure that the supply of radioisotopes can continue. It is in their interests, not just ours, for that to happen. That brings me on to my point about those matters that are UK responsibilities, and the broader question of leadership. There are some areas - for example, the regulation of staff and medicines - where these are actually UK responsibilities. The challenge is how open the relationship is between the UK Government and the devolved Governments across the United Kingdom, and how information is shared and used. While, of course, we have varying views on what should happen in the coming weeks and after 29 March, it is in all of our interests for the health and social care systems across the UK to share as much information as possible, in whatever form of Brexit may or may not take place. So, I am keen that not just the conversations that take place between officials continue, but that there is direct contact between Ministers. I have previously written to Matt Hancock. I know that Jeane Freeman, the Scottish Cabinet Secretary for health, well-being and sport, has also written requesting a face-to-face meeting. I've written again to do so as well. It stands in contrast to other members of the Government here in Wales. Lesley Griffiths and Kirsty Williams have had direct contact with ministerial counterparts. Not everyone will envy Lesley Griffiths her direct meetings with Michael Gove, but there is direct contact that needs to take place between the national Governments of the United Kingdom. I certainly will continue to pursue that because there is a leadership responsibility for all of us and, of course, for me here in Wales. On the ongoing conversation with Public Health Wales and taking forward their recommendations, you'll understand that the significant report was published at the start of this week, on Monday. I have read the executive summary. I have considered a range of parts of the report, but I won't try to pretend to you that I have taken forward all of the recommendations. There is, of course, an ongoing conversation taking place about the response of the health and care system here in Wales, bearing in mind that recommendations have been made. But, I am happy to update the Chamber as we formulate a fuller response that will, of course, have to evolve, given that the Brexit question is far from settled as we speak. On social care and the challenges of the social care workforce, I'm expecting to provide further updates to the taskforce that will meet more regularly now. We met last week. We will certainly need to meet in early February, and we are looking at a date, again not just to share information but to make choices. I will undertake to make sure that we update the Chamber on information, as and when we can share it, to make sure you are aware of the steps and measures that we are taking across the whole system. I'm also doing the same on updating on medicines - medicines management and supply issues, and the assurances we received, and the reality of those, including the conversations that we do have with representatives of the pharmaceutical industry here in Wales as well. On clinical consumables, there are different products that are regularly used between the health system in Wales, England and Scotland, so a range of those things will be available on a UK basis. We'll need to make sure that all of the various clinical consumables we would want to continue to use in Wales are available. So, I am definitely looking at arrangements to make that available, and for the necessary amounts of stock to be available too. And I'll have more to say when I'm able to make a definitive decision on that in the coming weeks as well. So, you can expect to hear more updates in writing from me over the coming weeks.
Welsh: Diolch am y sylwadau a'r gyfres o gwestiynau. Yn sicr ni allaf roi'r holl fanylion y gallwn i eu gwneud. Byddwn yn mynd ag amser nifer o Weinidogion eraill. Gallem dreulio'r prynhawn cyfan yn siarad dim ond am yr holl feysydd gwahanol ac amrywiol a fydd yn effeithio ar y system iechyd a gofal cymdeithasol os oes Brexit heb gytundeb. O ran radioisotopau, rwyf wedi dweud hyn yn gyson ynghylch yr her nid yn unig o ddod â radioisotopau i mewn i'r wlad, ond heriau ynglŷn â rheoleiddio o ran a all gweithgynhyrchwyr yn gyfreithiol fewnforio radioisotopau i'r Deyrnas Unedig, yn enwedig os yw'r Deyrnas Unedig yn parhau gyda'r cynnig presennol i adael Euratom a bod Brexit heb gytundeb. Mae sgyrsiau'n digwydd am hynny. Mae Cymdeithas Feddygol Prydain ei hun, er enghraifft, wedi cynhyrchu cyfarwyddyd yn crybwyll ambell her ynglŷn â hynny. Mae Llywodraeth y DU ar hyn o bryd yn dweud bod ganddi - neu ei bod hi'n ffyddiog y bydd ganddi - drefniadau ar waith i wneud yn siŵr y gall y cyflenwad o radioisotopau barhau. Mae o fudd iddi hi, nid yn unig o fudd i ninnau, i hynny ddigwydd. Daw hynny â mi at fy mhwynt i ynghylch y materion hynny y mae'r DU yn gyfrifol amdanyn nhw, a'r cwestiwn ehangach o arweinyddiaeth. Ceir rhai meysydd - er enghraifft, rheoleiddio staff a meddyginiaethau - lle mai cyfrifoldeb y DU yw'r rhain mewn gwirionedd. Yr her yw pa mor agored yw'r berthynas rhwng Llywodraeth y DU a'r llywodraethau datganoledig ledled y Deyrnas Unedig, a sut caiff gwybodaeth ei rhannu a'i defnyddio. Er, bod gennym ni, wrth gwrs, safbwyntiau gwahanol ar yr hyn a ddylai ddigwydd yn ystod yr wythnosau nesaf ac ar ôl 29 Mawrth, mae o fudd i bob un ohonom fod systemau i echyd a gofal cymdeithasol ledled y DU yn rhannu cymaint o wybodaeth â phosib, gyda pha fath bynnag o Brexit a allai ddigwydd neu beidio. Felly, rwy'n awyddus nid yn unig i'r sgyrsiau hynny rhwng swyddogion barhau, ond bod cyswllt uniongyrchol rhwng Gweinidogion. Rwyf wedi ysgrifennu o'r blaen at Matt Hancock. Rwy'n gwybod bod Jeane Freeman, Ysgrifennydd Cabinet yr Alban dros iechyd, lles a chwaraeon, wedi ysgrifennu hefyd yn gofyn am gyfarfod wyneb yn wyneb. Rwyf wedi ysgrifennu unwaith eto i ofyn hynny hefyd. Mae hynny mewn gwrthgyferbyniad i Aelodau eraill y Llywodraeth yma yng Nghymru. Mae Lesley Griffiths a Kirsty Williams wedi cael cyswllt uniongyrchol â Gweinidogion eraill. Nid pawb fydd yn eiddigeddus o Lesley Griffiths â'i chyfarfodydd uniongyrchol â Michael Gove, ond mae angen cyswllt uniongyrchol rhwng llywodraethau cenedlaethol y Deyrnas Unedig. Byddaf yn sicr yn parhau i fynd ar drywydd hynny oherwydd mae c yfrifoldeb arweinyddiaeth ar bob un ohonom ni ac, wrth gwrs, arnaf innau yma yng Nghymru. Ynglŷn â'r sgwrs barhaus gyda Iechyd Cyhoeddus Cymru a gweithredu eu hargymhellion, rydych chi'n deall y cyhoeddwyd yr adroddiad sylweddol ar ddechrau'r wythnos hon, ddydd Llun. Rwyf wedi darllen y crynodeb gweithredol. Rwyf wedi ystyried amryw o rannau'r adroddiad, ond wnaf i ddim ceisio cymryd arnaf fy mod i wedi gweithredu ar yr holl argymhellion. Wrth gwrs, mae sgwrs barhaus yn digwydd ynghylch ymateb y system iechyd a gofal yma yng Nghymru, o gofio bod argymhellion wedi'u gwneud. Ond, rwy'n hapus i roi'r wybodaeth ddiweddaraf i'r Siambr wrth inni lunio ymateb llawnach a fydd, wrth gwrs, yn gorfod esblygu, gan fod cwestiwn Brexit ymhell o fod wedi ei ddatrys wrth inni siarad. Ynghylch gofal cymdeithasol a heriau'r gweithlu gofal cymdeithasol, rwy'n disgwyl rhoi diweddariadau pellach i'r tasglu a fydd yn cyfarfod yn fwy rheolaidd bellach. Cafwyd cyfarfod yr wythnos diwethaf. Yn sicr bydd angen inni gyfarfod yn gynnar ym mis Chwefror, ac rydym yn ystyried dyddiad, eto nid yn unig i rannu gwybodaeth, ond i wneud dewisiadau. Byddaf yn ymrwymo i wneud yn siŵr ein bod ni'n rhoi'r wybodaeth ddiweddaraf i'r Siambr, pan fyddwn yn gallu gwneud hynny, i wneud yn siŵr eich bod yn ymwybodol o'r hyn yr ydym ni'n ei wneud a'r mesurau yr ydym ni'n eu gweithredu drwy'r system gyfan. Rwyf hefyd yn gwneud yr un peth ynglŷn â rhoi'r wybodaeth ddiweddaraf am feddyginiaethau - materion rheoli a chyflenwi meddyginiaethau, a'r sicrwydd yr ydym ni wedi'i gael, a realiti hynny, gan gynnwys y sgyrsiau gyda chynrychiolwyr y diwydiant fferyllol yma yng Nghymru hefyd. O ran nwyddau traul clinigol, mae yna gynhyrchion gwahanol a ddefnyddir yn rheolaidd rhwng y system iechyd yng Nghymru, Lloegr a'r Alban, felly bydd amrywiaeth o'r pethau hynny ar gael i'r DU gyfan. Bydd angen inni wneud yn siŵr bod pob un o'r defnyddiau traul clinigol amrywiol yr ydym ni eisiau parhau i'w defnyddio yng Nghymru ar gael. Felly, rwy'n bendant yn edrych ar y trefniadau i sicrhau bod hynny ar gael, ac i'r symiau angenrheidiol o stoc fod ar gael hefyd. Bydd gennyf fwy i'w ddweud pan fyddaf yn gallu gwneud penderfyniad terfynol ar hynny yn yr wythnosau nesaf hefyd. Felly, gallwch ddisgwyl clywed rhagor o ddiweddariadau ysgrifenedig gennyf dros yr wythnosau nesaf.